Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways
Coronavirus disease (COVID-19) is caused by SARS-CoV-2 virus, which can result in serious respiratory illnesses such as pneumonia leading to respiratory failure. It was first reported in Wuhan, Hubei, China, in December 2019 and rapidly spread globally, becoming a pandemic in March 2020. Among comor...
Saved in:
Main Authors: | Ersilia Nigro, Fabio Perrotta, Rita Polito, Vito D’Agnano, Filippo Scialò, Andrea Bianco, Aurora Daniele |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2020/8896536 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis
by: Rita Polito, et al.
Published: (2019-01-01) -
Multifactorial Induction of a “Scleroderma‐Like Pattern” Without Underlying Connective Tissue Disease: Diagnostic and Therapeutic Implications
by: Angelo Nigro
Published: (2025-01-01) -
Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation?
by: Jinyang An, et al.
Published: (2025-01-01) -
THE SOLANUM TUBEROSUM KNOWLEDGE BASE: THE SECTION ON MOLECULAR-GENETIC REGULATION OF METABOLIC PATHWAYS
by: T. V. Ivanisenko, et al.
Published: (2018-03-01) -
Sarcopenia and Its Implications for Metabolic Health
by: Gary R. Hunter, et al.
Published: (2019-01-01)